SC 13D

Company

NYMOX PHARMACEUTICAL CORP

Filed

August 27, 2015

Accession Number

0001651844-15-000001

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →